Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients…
Go to article Click Here
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients…
Go to article Click Here
On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest...
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against...
New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative LOS ANGELES, Nov....